NMDA [N-methyl-D-aspartate] enhancers in the treatment of schizophrenia: sarcosine vs. d-serine
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs D-serine (Primary) ; Sarcosine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 31 Jul 2007 New trial record.
- 26 Jun 2007 Biomarkers information updated